Yes, Valium (diazepam) is still prescribed and remains FDA-approved for several medical conditions. It has never been pulled from the market or restricted to a single use. That said, prescribing patterns have shifted significantly since the drug’s peak popularity in the 1970s, and doctors today are more cautious about when and how long they use it.
What Valium Is Still Prescribed For
Valium carries active FDA approval for four categories of use: anxiety disorders (or short-term relief of anxiety symptoms), acute alcohol withdrawal, skeletal muscle spasms, and as an add-on treatment for seizure disorders. It remains classified as a Schedule IV controlled substance by the DEA, the same category as other commonly prescribed benzodiazepines like Xanax, Klonopin, and Ativan.
In emergency and hospital settings, Valium plays a particularly important role. The American Epilepsy Society lists intravenous diazepam as one of the recommended first-line treatments for prolonged seizures and status epilepticus, alongside IV lorazepam and intramuscular midazolam. For alcohol withdrawal, major academic medical centers like UCSF still use diazepam as a cornerstone of their treatment protocols, with dosing scaled to the severity of withdrawal symptoms.
Why It’s Less Common Than It Used To Be
While Valium hasn’t gone away, it’s no longer the go-to choice for everyday anxiety the way it was decades ago. Several factors have pushed it down the prescribing hierarchy. SSRIs and other antidepressants are now considered first-line treatments for generalized anxiety disorder and panic disorder, largely because they don’t carry the same risk of dependence. When a benzodiazepine is needed, doctors often reach for shorter-acting options like lorazepam or alprazolam instead.
The reason comes down to how long Valium stays in your body. Diazepam has a half-life of roughly 48 hours, meaning it takes about two days for your body to clear just half the dose. Its primary breakdown product remains active for up to 100 hours. By comparison, shorter-acting benzodiazepines clear the system much faster. This long duration can be an advantage in certain medical situations (like preventing breakthrough seizures or smoothing out alcohol withdrawal), but for routine anxiety treatment it increases the risk of excessive sedation and accumulation with repeated doses.
Prescribing guidelines in several countries now recommend limiting benzodiazepine use for anxiety to a maximum of two to four weeks. In England, overall benzodiazepine dispensing dropped 27% between 2014 and 2022. In Ireland, where prescribing data is tracked by individual drug, diazepam dispensing rates held relatively steady over that same period (around 258 to 265 per 1,000 eligible patients), suggesting it hasn’t disappeared but also isn’t growing.
Where Valium Still Has an Edge
Valium’s long half-life, while a drawback for general anxiety, is exactly what makes it useful in specific clinical scenarios. In alcohol withdrawal, the drug’s slow, steady clearance provides a smoother tapering effect, reducing the risk of rebound symptoms or breakthrough seizures that can occur with shorter-acting medications. Hospitals rely on this property when managing patients through the most dangerous phase of withdrawal.
For muscle spasticity caused by conditions like cerebral palsy, spinal cord injuries, or stiff-person syndrome, diazepam remains a recognized treatment option. Its muscle-relaxing properties are well established, and the sustained duration of action means fewer doses throughout the day. It’s also used short-term for acute muscle spasms related to injuries or inflammation.
Risks That Have Changed Prescribing
Valium now carries a boxed warning, the FDA’s most serious safety alert, covering three areas: the danger of combining it with opioids, the potential for abuse and addiction, and the risk of physical dependence and withdrawal reactions. The opioid warning is relatively recent and reflects data showing that taking benzodiazepines alongside opioid painkillers significantly increases the risk of fatal respiratory depression. This warning applies to all benzodiazepines, not just Valium, but it has made prescribers more cautious across the board.
Physical dependence can develop even at prescribed doses, particularly with regular use beyond a few weeks. Stopping abruptly after prolonged use can trigger withdrawal symptoms ranging from rebound anxiety and insomnia to, in severe cases, seizures. This is one reason guidelines now emphasize keeping treatment courses as short as possible.
Special Concerns for Older Adults
Valium is specifically flagged as a medication to avoid in people over 65. The American Geriatrics Society’s Beers Criteria, a widely used reference for safe prescribing in older adults, gives it a strong “avoid” recommendation. The reasoning is straightforward: older adults are more sensitive to benzodiazepines, and their bodies metabolize long-acting versions like diazepam much more slowly. This leads to drug accumulation and a higher risk of cognitive impairment, delirium, falls, fractures, and car accidents. When an older adult does need a benzodiazepine, shorter-acting alternatives with simpler metabolism are generally preferred.
What This Means in Practice
If your doctor prescribes Valium today, it’s likely for a specific, time-limited purpose: managing acute alcohol withdrawal in a hospital, controlling active seizures, treating a short bout of severe muscle spasms, or bridging a period of intense anxiety while a longer-term treatment takes effect. You’re less likely to receive an open-ended prescription for daily anxiety management, which was common practice in earlier decades.
Generic diazepam is widely available and inexpensive, which keeps it accessible in settings where cost matters. The brand name Valium itself is less commonly dispensed than the generic, but the active drug remains a standard part of hospital formularies and outpatient prescribing when the clinical situation calls for it.